Number of the records: 1  

Amides derived from heteroaromatic amines and selected steryl hemiesters

  1. 1.
    SYSNO ASEP0398419
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleAmides derived from heteroaromatic amines and selected steryl hemiesters
    Author(s) Bildziukevich, Uladzimir (UEB-Q) RID, ORCID
    Rárová, L. (CZ)
    Šaman, David (UOCHB-X) RID, ORCID
    Havlíček, Libor (UEB-Q) RID, ORCID
    Drašar, P. (CZ)
    Wimmer, Zdeněk (UEB-Q) RID, ORCID
    Source TitleSteroids. - : Elsevier - ISSN 0039-128X
    Roč. 78, č. 14 (2013), s. 1347-1352
    Number of pages6 s.
    Languageeng - English
    CountryUS - United States
    KeywordsHeteroaromatic amine ; Cholesterol ; Lanosterol
    Subject RIVFR - Pharmacology ; Medidal Chemistry
    R&D ProjectsGAP503/11/0616 GA ČR - Czech Science Foundation (CSF)
    Institutional supportUEB-Q - RVO:61389030 ; UOCHB-X - RVO:61388963
    UT WOS000328303300006
    DOI10.1016/j.steroids.2013.10.003
    AnnotationThe current interest of the team has been focused on investigation of novel amides with potential cytotoxicity. The presented series of compounds was synthesized from selected steryl hemiesters and heteroaromatic amines. The synthetic protocol was designed in a simple and economic way, and divided into several general methodologies applicable to the compounds synthesized. The cytotoxicity was tested on cells derived from human T-lymphoblastic leukemia, breast adenocarcinoma and cervical cancer, and compared with tests on normal human fibroblasts. Most of the lanosterol-based compounds (3–5 and 7–10) showed medium to good cytotoxicity, while only two derivatives of cholesterol (18 and 19) showed medium cytotoxicity on human T-lymphoblastic leukemia cell line.
    WorkplaceInstitute of Experimental Botany
    ContactDavid Klier, knihovna@ueb.cas.cz, Tel.: 220 390 469
    Year of Publishing2014
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.